US2010222293A1PendingUtilityA1

Modulation of sperm motility

Assignee: BONANNI GUGLIELMOPriority: Feb 27, 2007Filed: Feb 27, 2008Published: Sep 2, 2010
Est. expiryFeb 27, 2027(~0.6 yrs left)· nominal 20-yr term from priority
A61K 31/7076G01N 33/5091A61P 15/08G01N 33/483A61D 19/00C12Q 1/00G01N 33/50
43
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Provided are methods of enhancing the fertility of mammalian spermatozoa involving contacting the spermatozoa with adenosine 5′-triphosphate and method of fertilization using spermatozoa treated in this way.

Claims

exact text as granted — not AI-modified
1 . A method of enhancing the motility of a mammalian spermatozoon, the method comprising contacting a spermatozoon from a mammalian subject with extracellular adenosine 5′-triphosphate (ATP). 
   
   
       2 . The method of  claim 1 , wherein, prior to the contacting, a plurality of spermatozoa from the mammalian subject are identified as having decreased motility. 
   
   
       3 . The method of  claim 1 , wherein the mammalian subject is a human subject. 
   
   
       4 . The method of  claim 1 , wherein the mammalian subject is an equine subject. 
   
   
       5 . The method of  claim 1 , wherein the contacting comprises culturing the spermatazoon in a physiological medium with the ATP dissolved therein. 
   
   
       6 . The method of  claim 1 , wherein the contacting is for about 10 minutes to about 120 minutes. 
   
   
       7 . The method of  claim 1 , wherein the contacting is for about 60 minutes. 
   
   
       8 . The method of  claim 1 , wherein the concentration of extracellular ATP at the initiation of the contacting is about 100 uM to about 5 mM. 
   
   
       9 . The method of  claim 1 , wherein the concentration of extracellular ATP at the initiation of the contacting is about 2.5 mM. 
   
   
       10 . The method of  claim 1 , wherein the contacting is at about 18° C. to about 37° C. 
   
   
       11 . The method of  claim 1 , wherein the contacting is at about 37° C. 
   
   
       12 . The method of  claim 1 , wherein prior to the contacting, the spermatozoon is substantially separated from seminal plasma. 
   
   
       13 . The method of  claim 1 , wherein, after the contacting, the motility of the spermatozoon is assessed. 
   
   
       14 . The method of  claim 1 , wherein the contacting occurs in a mammalian female reproductive tract. 
   
   
       15 . The method of  claim 14 , wherein the mammalian female is a human. 
   
   
       16 . The method of  claim 14 , wherein the mammalian female is an equine subject. 
   
   
       17 . A method of fertilizing a mammalian egg, the method comprising contacting a mammalian egg with a mammalian spermatozoon that has undergone the method of  claim 1 . 
   
   
       18 . The method of  claim 17 , wherein the contacting of the mammalian egg occurs in vitro. 
   
   
       19 . The method of  claim 17 , wherein, after the contacting of the mammalian egg and the contacted egg has been fertilized and become an embryo, the mammalian egg is placed in a mammalian uterus. 
   
   
       20 . The method of  claim 17 , wherein the contacting of the mammalian egg occurs in vivo. 
   
   
       21 . The method of  claim 20 , wherein the contacting of the mammalian egg occurs in a female reproductive tract. 
   
   
       22 . The method of  claim 17 , wherein the mammalian spermatozoon is a human spermatozoon and the mammalian egg is a human egg. 
   
   
       23 . The method of  claim 17 , wherein the mammalian spermatozoon is an equine spermatozoon and the mammalian egg is an equine egg. 
   
   
       24 . The method of  claim 1 , wherein the spermatozoon is obtained from an asthenozoospermic subject. 
   
   
       25 . The method of  claim 17 , wherein the spermatozoon is obtained from an asthenozoospermic subject.

Join the waitlist — get patent alerts

Track US2010222293A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.